Sponsor
Auron Therapeutics Inc.
55 Chapel Street Suite 102, 02458-1060, United States
About the sponsor
Auron Therapeutics Inc. focuses on relapsed/refractory Acute Myeloid Leukemia and myelodysplastic syndromes, with research centered on difficult-to-treat blood cancers that require new therapeutic options.
- Acute Myeloid Leukemia
- Myelodysplastic syndromes
- Relapsed disease
- Refractory disease
The sponsor’s clinical activity is directed toward oncology settings where treatment resistance and disease recurrence remain major concerns.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.